279 related articles for article (PubMed ID: 15528988)
1. Frameshift deletion mechanisms in Egyptian Duchenne and Becker muscular dystrophy families.
Elhawary NA; Shawky RM; Hashem N
Mol Cells; 2004 Oct; 18(2):141-9. PubMed ID: 15528988
[TBL] [Abstract][Full Text] [Related]
2. Re-evaluation of reading frame-shift hypothesis in Duchenne and Becker muscular dystrophy.
Pandey GS; Kesari A; Mukherjee M; Mittal RD; Mittal B
Neurol India; 2003 Sep; 51(3):367-9. PubMed ID: 14652441
[TBL] [Abstract][Full Text] [Related]
3. Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy.
Béroud C; Tuffery-Giraud S; Matsuo M; Hamroun D; Humbertclaude V; Monnier N; Moizard MP; Voelckel MA; Calemard LM; Boisseau P; Blayau M; Philippe C; Cossée M; Pagès M; Rivier F; Danos O; Garcia L; Claustres M
Hum Mutat; 2007 Feb; 28(2):196-202. PubMed ID: 17041910
[TBL] [Abstract][Full Text] [Related]
4. Deletion analysis of the dystrophin gene in Duchenne and Becker muscular dystrophy patients: use in carrier diagnosis.
Kumari D; Mital A; Gupta M; Goyle S
Neurol India; 2003 Jun; 51(2):223-6. PubMed ID: 14571009
[TBL] [Abstract][Full Text] [Related]
5. Amplification of selected exons by polymerase chain reaction enables determination of the translational reading frame of dystrophin mRNA resulting from deletion mutations.
Kitoh Y; Matsuo M; Nishio H; Nakamura H
Kobe J Med Sci; 1994 Apr; 40(2):39-48. PubMed ID: 7823533
[TBL] [Abstract][Full Text] [Related]
6. Proximal dystrophin gene deletions and protein alterations in becker muscular dystrophy.
Novaković I; Bojić D; Todorović S; Apostolski S; Luković L; Stefanović D; Milasin J
Ann N Y Acad Sci; 2005 Jun; 1048():406-10. PubMed ID: 16154963
[TBL] [Abstract][Full Text] [Related]
7. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.
Deburgrave N; Daoud F; Llense S; Barbot JC; Récan D; Peccate C; Burghes AH; Béroud C; Garcia L; Kaplan JC; Chelly J; Leturcq F
Hum Mutat; 2007 Feb; 28(2):183-95. PubMed ID: 17041906
[TBL] [Abstract][Full Text] [Related]
8. MLPA analysis/complete sequencing of the DMD gene in a group of Bulgarian Duchenne/Becker muscular dystrophy patients.
Todorova A; Todorov T; Georgieva B; Lukova M; Guergueltcheva V; Kremensky I; Mitev V
Neuromuscul Disord; 2008 Aug; 18(8):667-70. PubMed ID: 18653336
[TBL] [Abstract][Full Text] [Related]
9. Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.
Al-Jumah M; Majumdar R; Al-Rajeh S; Chaves-Carballo E; Salih MM; Awada A; Al-Shahwan S; Al-Uthaim S
Saudi Med J; 2002 Dec; 23(12):1478-82. PubMed ID: 12518196
[TBL] [Abstract][Full Text] [Related]
10. Molecular deletion patterns in Duchenne and Becker muscular dystrophy patients from KwaZulu Natal.
Hallwirth Pillay KD; Bill PL; Madurai S; Mubaiwa L; Rapiti P
J Neurol Sci; 2007 Jan; 252(1):1-3. PubMed ID: 17141273
[TBL] [Abstract][Full Text] [Related]
11. Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients.
Shomrat R; Gluck E; Legum C; Shiloh Y
Am J Med Genet; 1994 Feb; 49(4):369-73. PubMed ID: 8160727
[TBL] [Abstract][Full Text] [Related]
12. [Combining approach with multiplex PCR and MLPA to detect deletion and duplication in DMD patients, carriers, and prenatal diagnosis].
Li H; Ding J; Wang W; Chen Y; Lu W; Shao H; Wu BL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):318-22. PubMed ID: 19504448
[TBL] [Abstract][Full Text] [Related]
13. Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients.
Helderman-van den Enden AT; Straathof CS; Aartsma-Rus A; den Dunnen JT; Verbist BM; Bakker E; Verschuuren JJ; Ginjaar HB
Neuromuscul Disord; 2010 Apr; 20(4):251-4. PubMed ID: 20153965
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic Becker muscular dystrophy in a family with a multiexon deletion.
Ferreiro V; Giliberto F; Muñiz GM; Francipane L; Marzese DM; Mampel A; Roqué M; Frechtel GD; Szijan I
Muscle Nerve; 2009 Feb; 39(2):239-43. PubMed ID: 19012301
[TBL] [Abstract][Full Text] [Related]
15. [Deletions in the dystrophin gene and its phenotype expression].
Lalić T; Guć-Sćekić M; Djurisić M; Radivojević D; Zamurović D; Todorović S
Srp Arh Celok Lek; 2001; 129 Suppl 1():3-5. PubMed ID: 15637982
[TBL] [Abstract][Full Text] [Related]
16. Molecular diagnosis of Duchenne/Becker muscular dystrophy by polymerase chain reaction and microsatellite analysis.
Kim UK; Chae JJ; Lee SH; Lee CC; Namkoong Y
Mol Cells; 2002 Jun; 13(3):385-8. PubMed ID: 12132577
[TBL] [Abstract][Full Text] [Related]
17. Screening of dystrophin gene deletions in Malaysian patients with Duchenne muscular dystrophy.
Marini M; Salmi AA; Watihayati MS; SMardziah MD; Zahri MK; Hoh BP; Ankathil R; Lai PS; Zilfalil BA
Med J Malaysia; 2008 Mar; 63(1):31-4. PubMed ID: 18935728
[TBL] [Abstract][Full Text] [Related]
18. Intragenic deletions in the dystrophin gene in 211 Pakistani Duchenne muscular dystrophy patients.
Hassan MJ; Mahmood S; Ali G; Bibi N; Waheed I; Rafiq MA; Ansar M; Ahmad W
Pediatr Int; 2008 Apr; 50(2):162-6. PubMed ID: 18353051
[TBL] [Abstract][Full Text] [Related]
19. Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?
Kerr TP; Sewry CA; Robb SA; Roberts RG
Hum Genet; 2001 Oct; 109(4):402-7. PubMed ID: 11702221
[TBL] [Abstract][Full Text] [Related]
20. [Molecular pathology of Duchenne and Becker muscular dystrophy].
Gilgenkrantz H; Chelly J; Récan D; Chafey P; Kaplan JC
C R Seances Soc Biol Fil; 1992; 186(4):349-53. PubMed ID: 1301222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
